Related references
Note: Only part of the references are listed.LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival
Li-Xia Peng et al.
CANCER LETTERS (2021)
Foxq1 promotes metastasis of nasopharyngeal carcinoma by inducing vasculogenic mimicry via the EGFR signaling pathway
Yunfan Luo et al.
CELL DEATH & DISEASE (2021)
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival
Fahed A. Elian et al.
BREAST CANCER-TARGETS AND THERAPY (2021)
Antitumour immunity regulated by aberrant ERBB family signalling
Shogo Kumagai et al.
NATURE REVIEWS CANCER (2021)
IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
Phaik Ju Teoh et al.
HAEMATOLOGICA (2020)
EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2
Shengnan Chen et al.
CARCINOGENESIS (2020)
Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease
Mitchell I. Parker et al.
CELLULAR SIGNALLING (2020)
Curcumin enhances radiosensitization of nasopharyngeal carcinoma by regulating circRNA network
Jiabin Yang et al.
MOLECULAR CARCINOGENESIS (2020)
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy
Tanner Dalton et al.
BLOOD (2020)
Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma
Chen Chen et al.
CANCER MEDICINE (2020)
Distinctive EBV infection characteristics in children from a developing country
N. M. Ferressini Gerpe et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
Adileh Ayati et al.
BIOORGANIC CHEMISTRY (2020)
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
Rasmus Siersbaek et al.
CANCER CELL (2020)
Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
Ming-Ying Lan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma
Zhaodong Fei et al.
RADIATION ONCOLOGY (2020)
Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
Yuri Ueda et al.
FRONTIERS IN ONCOLOGY (2020)
Erlotinib enhanced chemoradiotherapy sensitivity via inhibiting DNA damage repair in nasopharyngeal carcinoma CNE2 cells
Yunxia Zhang et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles
Laura C. Zanetti-Domingues et al.
CELLS (2020)
Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer
Laura C. Zanetti-Domingues et al.
CELLS (2020)
EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K/AKT pathway-suppressed ROS
Fei Li et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
Extracellular Vesicle Dissemination of Epidermal Growth Factor Receptor and Ligands and Its Role in Cancer Progression
Thomas Frawley et al.
CANCERS (2020)
Nimotuzumab plus platinum-based chemotherapyversusplatinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Yunshu Zhu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Retrospective study comparing anti-EGFR monoclonal antibody plus cisplatin-based chemoradiotherapy versus chemoradiotherapy alone for stage II-IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression
Linwei Mao et al.
CLINICAL OTOLARYNGOLOGY (2019)
VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
Zixi Liang et al.
CELL DEATH & DISEASE (2019)
Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles
Yugui Fu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
Christian Muenz
NATURE REVIEWS MICROBIOLOGY (2019)
Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study
Xue-Song Sun et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
Wang Zhi-Qiang et al.
BMC CANCER (2019)
Epithelial cell infection by Epstein-Barr virus
Jia Chen et al.
FEMS MICROBIOLOGY REVIEWS (2019)
Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer
Johan S. Nilsson et al.
SCIENTIFIC REPORTS (2019)
Alterations in cellular expression in EBV infected epithelial cell lines and tumors
Rachel Hood Edwards et al.
PLOS PATHOGENS (2019)
Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication
Wenmin Fu et al.
JOURNAL OF VIROLOGY (2019)
Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis
Huali Yin et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Highly Uniform Synthesis of Selenium Nanoparticles with EGFR Targeting and Tumor Microenvironment-Responsive Ability for Simultaneous Diagnosis and Therapy of Nasopharyngeal Carcinoma
Jing Huang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Simultaneous Inhibition of EGFR and HER2 via Afatinib Augments the Radiosensitivity of Nasopharyngeal Carcinoma Cells
Fangling Huang et al.
JOURNAL OF CANCER (2019)
EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter
Feng Shi et al.
THERANOSTICS (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
Eskil Eskilsson et al.
NEURO-ONCOLOGY (2018)
Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis
Hao Peng et al.
BMC CANCER (2018)
PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR
Qinghai Lin et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2018)
Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma
Mei Lin et al.
ORAL ONCOLOGY (2018)
Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma
Xiaoyan Si et al.
THORACIC CANCER (2018)
Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis
Li-Rong Wu et al.
JOURNAL OF CANCER (2018)
Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry
Hua Zhang et al.
NATURE MICROBIOLOGY (2018)
Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma
Ji-Jin Yao et al.
CANCER BIOLOGY & THERAPY (2018)
Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing
Chaofeng Tu et al.
CARCINOGENESIS (2018)
Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma
Louise Soo Yee Tan et al.
ONCOIMMUNOLOGY (2018)
Epstein-Barr virus infection and nasopharyngeal carcinoma
Sai Wah Tsao et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
The Role of ErbB Receptors in Infection
Jemima Ho et al.
TRENDS IN MICROBIOLOGY (2017)
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Leah Fitzsimmons et al.
VIRUSES-BASEL (2017)
Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
Xiaomin Liu et al.
ONCOTARGET (2017)
Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up
Rui You et al.
THERANOSTICS (2017)
A role for ErbB signaling in the induction of reactive astrogliosis
Jing Chen et al.
CELL DISCOVERY (2017)
EGFR-targeted therapies in the post-genomic era
Mary Jue Xu et al.
CANCER AND METASTASIS REVIEWS (2017)
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy
Siraj M. Ali et al.
CANCER (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications
Xiaojun Tan et al.
TRENDS IN CELL BIOLOGY (2016)
Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers
Deilson Elgui de Oliveira et al.
TRENDS IN MICROBIOLOGY (2016)
In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma
Cong Xue et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Epstein-Barr virus: more than 50 years old and still providing surprises
Lawrence S. Young et al.
NATURE REVIEWS CANCER (2016)
DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway
Wei Huang et al.
MEDICAL ONCOLOGY (2015)
Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
Rachel Hood Edwards et al.
MBIO (2015)
Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
Hong-Bo Wang et al.
NATURE COMMUNICATIONS (2015)
Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance
Robert M. Jotte et al.
CANCER MEDICINE (2015)
p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study
Peng Zhang et al.
ONCOLOGY LETTERS (2015)
MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma
Yanyang Liu et al.
CANCER CELL INTERNATIONAL (2014)
Oropharyngeal cancers: Relationship between epidermal growth factor receptor alterations and human papillomavirus status
H. Mirghani et al.
EUROPEAN JOURNAL OF CANCER (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
Receptor Tyrosine Kinases: Legacy of the First Two Decades
Joseph Schlessinger
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma
Lei Ma et al.
FEBS JOURNAL (2013)
DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells
Xiangling Feng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells
Yang Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma
Grace Tin-Yun Chung et al.
JOURNAL OF PATHOLOGY (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
Benoit You et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
Christopher W. Dawson et al.
SEMINARS IN CANCER BIOLOGY (2012)
How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns
Ian C. Zachary
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells
Vivian Wai Yan Lui et al.
INVESTIGATIONAL NEW DRUGS (2011)
Epstein-Barr Virus LMP1 Activates EGFR, STAT3, and ERK through Effects on PKCδ
Che-Pei Kung et al.
JOURNAL OF VIROLOGY (2011)
Epidermal growth factor receptor (EGFR) abundance correlates with p53 and Bcl-2 accumulation and patient age in a small cohort of North African nasopharyngeal carcinoma patients
Mehdi Bourouba et al.
EUROPEAN CYTOKINE NETWORK (2011)
Immunotherapy of Malignant Disease with Tumor Antigen-Specific Monoclonal Antibodies
Michael Campoli et al.
CLINICAL CANCER RESEARCH (2010)
Epstein-Barr Virus Latent Membrane Protein 1 Modulates Distinctive NF-κB Pathways through C-Terminus-Activating Region 1 To Regulate Epidermal Growth Factor Receptor Expression
Che-Pei Kung et al.
JOURNAL OF VIROLOGY (2010)
Spatial control of EGF receptor activation by reversible dimerization on living cells
Inhee Chung et al.
NATURE (2010)
Human tumor virus utilizes exosomes for intercellular communication
David G. Meckes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
Ariel Talavera et al.
CANCER RESEARCH (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma
Daniel T. T. Chua et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: The relation to STAT3 activation and EGFR expression
Ning Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3
Che-Pei Kung et al.
JOURNAL OF VIROLOGY (2008)
Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 c-terminal-activating region 1 is mediated by NF-κB p50 Homodimer/Bcl-3 complexes
Natalie J. Thornburg et al.
JOURNAL OF VIROLOGY (2007)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1: Implications for EBV-mediated immortalization
V Saridakis et al.
MOLECULAR CELL (2005)
Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1
YG Tao et al.
EXPERIMENTAL CELL RESEARCH (2005)
Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro
CH Hsu et al.
ONCOLOGY (2005)
Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy
DTT Chua et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation
M Luftig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-κB transcription factor pathway
S Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis
JR Hsiao et al.
BRITISH JOURNAL OF CANCER (2003)
Functional analysis of EBV in nasopharyngeal carcinoma cells
HC Wu et al.
LABORATORY INVESTIGATION (2003)
The putative oncoprotein Bcl-3 induces cyclin d1 to stimulate G1 transition
SD Westerheide et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Direct phosphorylation of NF-κB1 p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis
A Salmerón et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
